Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis

BACKGROUND: Adherence to disease-modifying drugs (DMDs) is one of the key factors for achieving optimal clinical outcomes. Rebismart(®) is an injection device for subcutaneous administration of interferon beta-1a (INF β-1a) that is also able to monitor adherence objectively. The aim of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Edo Solsona, María Dolores, Monte Boquet, Emilio, Casanova Estruch, Bonaventura, Poveda Andrés, José Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338953/
https://www.ncbi.nlm.nih.gov/pubmed/28280313
http://dx.doi.org/10.2147/PPA.S127508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338953/
https://www.ncbi.nlm.nih.gov/pubmed/28280313
http://dx.doi.org/10.2147/PPA.S127508

Ejemplares similares